APO RESEARCH · REPORT
Peptide Synthesis
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Product & engineering
Understand the product.
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Selected research
Industry Research
Peptide Synthesis Industry Research Report 2026
Market perspective
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Global Peptide Synthesis key players include Bachem, PolyPeptide, USV Peptides, Thermofischer, GL Biochem etc.
Europe is the largest market, with a share over 30%, followed by North America and Asia-Pacific, both have a share over 50% percent.
Read the full market overview
Report Scope
This report quantifies the global Peptide Synthesis market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Peptide Synthesis.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peptide Synthesis Market by Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
GL Biochem
Hybio
Bio Basic
JPT
Genscript
Xinbang
ScinoPharm
21st Century Bio
CPC Scientific
LifeTein
AnaSpec
New England Peptide
Biomatik
Proimmune
Peptide Synthesis Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Peptide Synthesis Segment by Application
Commercial
Academic Research
Peptide Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Peptide Synthesis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Peptide Synthesis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Peptide Synthesis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CRO Peptides
- CMO Peptides
- Generic API Peptides
Applications
- Commercial
- Academic Research
Companies covered
- Bachem
- PolyPeptide
- USV Peptides
- Thermofischer
- GL Biochem
- Hybio
- Bio Basic
- JPT
- Genscript
- Xinbang
- ScinoPharm
- 21st Century Bio
- CPC Scientific
- LifeTein
- AnaSpec
- New England Peptide
- Biomatik
- Proimmune
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Peptide Synthesis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 CRO Peptides
- 2.2.3 CMO Peptides
- 2.2.4 Generic API Peptides
- 2.3 Peptide Synthesis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Commercial
- 2.3.3 Academic Research
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Peptide Synthesis Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Peptide Synthesis Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Peptide Synthesis Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Peptide Synthesis Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Peptide Synthesis Production by Manufacturers (2021-2026)
- 3.2 Global Peptide Synthesis Production Value by Manufacturers (2021-2026)
- 3.3 Global Peptide Synthesis Average Price by Manufacturers (2021-2026)
- 3.4 Global Peptide Synthesis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Peptide Synthesis Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Peptide Synthesis Manufacturers, Product Type & Application
- 3.7 Global Peptide Synthesis Manufacturers Established Date
- 3.8 Global Peptide Synthesis Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bachem
- 4.1.1 Bachem Peptide Synthesis Company Information
- 4.1.2 Bachem Peptide Synthesis Business Overview
- 4.1.3 Bachem Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Bachem Product Portfolio
- 4.1.5 Bachem Recent Developments
- 4.2 PolyPeptide
- 4.2.1 PolyPeptide Peptide Synthesis Company Information
- 4.2.2 PolyPeptide Peptide Synthesis Business Overview
- 4.2.3 PolyPeptide Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 PolyPeptide Product Portfolio
- 4.2.5 PolyPeptide Recent Developments
- 4.3 USV Peptides
- 4.3.1 USV Peptides Peptide Synthesis Company Information
- 4.3.2 USV Peptides Peptide Synthesis Business Overview
- 4.3.3 USV Peptides Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 USV Peptides Product Portfolio
- 4.3.5 USV Peptides Recent Developments
- 4.4 Thermofischer
- 4.4.1 Thermofischer Peptide Synthesis Company Information
- 4.4.2 Thermofischer Peptide Synthesis Business Overview
- 4.4.3 Thermofischer Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Thermofischer Product Portfolio
- 4.4.5 Thermofischer Recent Developments
- 4.5 GL Biochem
- 4.5.1 GL Biochem Peptide Synthesis Company Information
- 4.5.2 GL Biochem Peptide Synthesis Business Overview
- 4.5.3 GL Biochem Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 GL Biochem Product Portfolio
- 4.5.5 GL Biochem Recent Developments
- 4.6 Hybio
- 4.6.1 Hybio Peptide Synthesis Company Information
- 4.6.2 Hybio Peptide Synthesis Business Overview
- 4.6.3 Hybio Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Hybio Product Portfolio
- 4.6.5 Hybio Recent Developments
- 4.7 Bio Basic
- 4.7.1 Bio Basic Peptide Synthesis Company Information
- 4.7.2 Bio Basic Peptide Synthesis Business Overview
- 4.7.3 Bio Basic Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Bio Basic Product Portfolio
- 4.7.5 Bio Basic Recent Developments
- 4.8 JPT
- 4.8.1 JPT Peptide Synthesis Company Information
- 4.8.2 JPT Peptide Synthesis Business Overview
- 4.8.3 JPT Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 JPT Product Portfolio
- 4.8.5 JPT Recent Developments
- 4.9 Genscript
- 4.9.1 Genscript Peptide Synthesis Company Information
- 4.9.2 Genscript Peptide Synthesis Business Overview
- 4.9.3 Genscript Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Genscript Product Portfolio
- 4.9.5 Genscript Recent Developments
- 4.10 Xinbang
- 4.10.1 Xinbang Peptide Synthesis Company Information
- 4.10.2 Xinbang Peptide Synthesis Business Overview
- 4.10.3 Xinbang Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Xinbang Product Portfolio
- 4.10.5 Xinbang Recent Developments
- 4.11 ScinoPharm
- 4.11.1 ScinoPharm Peptide Synthesis Company Information
- 4.11.2 ScinoPharm Peptide Synthesis Business Overview
- 4.11.3 ScinoPharm Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 ScinoPharm Product Portfolio
- 4.11.5 ScinoPharm Recent Developments
- 4.12 21st Century Bio
- 4.12.1 21st Century Bio Peptide Synthesis Company Information
- 4.12.2 21st Century Bio Peptide Synthesis Business Overview
- 4.12.3 21st Century Bio Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 21st Century Bio Product Portfolio
- 4.12.5 21st Century Bio Recent Developments
- 4.13 CPC Scientific
- 4.13.1 CPC Scientific Peptide Synthesis Company Information
- 4.13.2 CPC Scientific Peptide Synthesis Business Overview
- 4.13.3 CPC Scientific Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 CPC Scientific Product Portfolio
- 4.13.5 CPC Scientific Recent Developments
- 4.14 LifeTein
- 4.14.1 LifeTein Peptide Synthesis Company Information
- 4.14.2 LifeTein Peptide Synthesis Business Overview
- 4.14.3 LifeTein Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 LifeTein Product Portfolio
- 4.14.5 LifeTein Recent Developments
- 4.15 AnaSpec
- 4.15.1 AnaSpec Peptide Synthesis Company Information
- 4.15.2 AnaSpec Peptide Synthesis Business Overview
- 4.15.3 AnaSpec Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 AnaSpec Product Portfolio
- 4.15.5 AnaSpec Recent Developments
- 4.16 New England Peptide
- 4.16.1 New England Peptide Peptide Synthesis Company Information
- 4.16.2 New England Peptide Peptide Synthesis Business Overview
- 4.16.3 New England Peptide Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 New England Peptide Product Portfolio
- 4.16.5 New England Peptide Recent Developments
- 4.17 Biomatik
- 4.17.1 Biomatik Peptide Synthesis Company Information
- 4.17.2 Biomatik Peptide Synthesis Business Overview
- 4.17.3 Biomatik Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.17.4 Biomatik Product Portfolio
- 4.17.5 Biomatik Recent Developments
- 4.18 Proimmune
- 4.18.1 Proimmune Peptide Synthesis Company Information
- 4.18.2 Proimmune Peptide Synthesis Business Overview
- 4.18.3 Proimmune Peptide Synthesis Production Capacity, Value and Gross Margin (2021-2026)
- 4.18.4 Proimmune Product Portfolio
- 4.18.5 Proimmune Recent Developments
5 Global Peptide Synthesis Production by Region
- 5.1 Global Peptide Synthesis Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Peptide Synthesis Production by Region: 2021-2032
- 5.2.1 Global Peptide Synthesis Production by Region: 2021-2026
- 5.2.2 Global Peptide Synthesis Production Forecast by Region (2027-2032)
- 5.3 Global Peptide Synthesis Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Peptide Synthesis Production Value by Region: 2021-2032
- 5.4.1 Global Peptide Synthesis Production Value by Region: 2021-2026
- 5.4.2 Global Peptide Synthesis Production Value Forecast by Region (2027-2032)
- 5.5 Global Peptide Synthesis Market Price Analysis by Region (2021-2026)
- 5.6 Global Peptide Synthesis Production and Value, YOY Growth
- 5.6.1 North America Peptide Synthesis Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Peptide Synthesis Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Peptide Synthesis Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Peptide Synthesis Production Value Estimates and Forecasts (2021-2032)
6 Global Peptide Synthesis Consumption by Region
- 6.1 Global Peptide Synthesis Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Peptide Synthesis Consumption by Region (2021-2032)
- 6.2.1 Global Peptide Synthesis Consumption by Region: 2021-2026
- 6.2.2 Global Peptide Synthesis Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Peptide Synthesis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Peptide Synthesis Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Peptide Synthesis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Peptide Synthesis Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Peptide Synthesis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Peptide Synthesis Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Peptide Synthesis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Peptide Synthesis Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Peptide Synthesis Production by Type (2021-2032)
- 7.1.1 Global Peptide Synthesis Production by Type (2021-2032) & (Kg)
- 7.1.2 Global Peptide Synthesis Production Market Share by Type (2021-2032)
- 7.2 Global Peptide Synthesis Production Value by Type (2021-2032)
- 7.2.1 Global Peptide Synthesis Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Peptide Synthesis Production Value Market Share by Type (2021-2032)
- 7.3 Global Peptide Synthesis Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Peptide Synthesis Production by Application (2021-2032)
- 8.1.1 Global Peptide Synthesis Production by Application (2021-2032) & (Kg)
- 8.1.2 Global Peptide Synthesis Production Market Share by Application (2021-2032)
- 8.2 Global Peptide Synthesis Production Value by Application (2021-2032)
- 8.2.1 Global Peptide Synthesis Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Peptide Synthesis Production Value Market Share by Application (2021-2032)
- 8.3 Global Peptide Synthesis Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Peptide Synthesis Value Chain Analysis
- 9.1.1 Peptide Synthesis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Peptide Synthesis Production Mode & Process
- 9.2 Peptide Synthesis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Peptide Synthesis Distributors
- 9.2.3 Peptide Synthesis Customers
10 Global Peptide Synthesis Analyzing Market Dynamics
- 10.1 Peptide Synthesis Industry Trends
- 10.2 Peptide Synthesis Industry Drivers
- 10.3 Peptide Synthesis Industry Opportunities and Challenges
- 10.4 Peptide Synthesis Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst